196 related articles for article (PubMed ID: 19174809)
1. Mesalazine and rifaximin in symptomatic uncomplicated diverticular disease.
Festi D; Colecchia A
Am J Gastroenterol; 2009 Feb; 104(2):532. PubMed ID: 19174809
[No Abstract] [Full Text] [Related]
2. Diverticular disease: what is the best long-term treatment?
Tursi A
Nat Rev Gastroenterol Hepatol; 2010 Feb; 7(2):77-8. PubMed ID: 20134488
[No Abstract] [Full Text] [Related]
3. Mesalazine for People with Diverticular Disease: A Systematic Review of Randomized Controlled Trials.
Iannone A; Ruospo M; Wong G; Barone M; Principi M; Di Leo A; Strippoli GFM
Can J Gastroenterol Hepatol; 2018; 2018():5437135. PubMed ID: 30320044
[TBL] [Abstract][Full Text] [Related]
4. Diverticulitis: new insights on the traditional point of view.
Moubax K; Urbain D
Acta Gastroenterol Belg; 2015; 78(1):38-48. PubMed ID: 26118576
[TBL] [Abstract][Full Text] [Related]
5. Mesalazine to treat symptomatic uncomplicated diverticular disease and to prevent acute diverticulitis occurrence. A systematic review with meta-analysis of randomized, placebo-controlled trials.
Picchio M; Elisei W; Tursi A
J Gastrointestin Liver Dis; 2018 Sep; 27(3):291-297. PubMed ID: 30240473
[TBL] [Abstract][Full Text] [Related]
6. Management of diverticular disease: is there room for rifaximin?
Papi C; Koch M; Capurso L
Chemotherapy; 2005; 51 Suppl 1():110-4. PubMed ID: 15855755
[TBL] [Abstract][Full Text] [Related]
7. Rifaximin plus mesalazine followed by mesalazine alone is highly effective in obtaining remission of symptomatic uncomplicated diverticular disease.
Brandimarte G; Tursi A
Med Sci Monit; 2004 May; 10(5):PI70-3. PubMed ID: 15114281
[TBL] [Abstract][Full Text] [Related]
8. Long-term treatment with mesalazine and rifaximin versus rifaximin alone for patients with recurrent attacks of acute diverticulitis of colon.
Tursi A; Brandimarte G; Daffinà R
Dig Liver Dis; 2002 Jul; 34(7):510-5. PubMed ID: 12236485
[TBL] [Abstract][Full Text] [Related]
9. Mesalazine for diverticular disease of the colon--a new role for an old drug.
Tursi A
Expert Opin Pharmacother; 2005 Jan; 6(1):69-74. PubMed ID: 15709884
[TBL] [Abstract][Full Text] [Related]
10. Expanding applications: the potential usage of 5-aminosalicylic acid in diverticular disease.
Tursi A; Joseph RE; Streck P
Dig Dis Sci; 2011 Nov; 56(11):3112-21. PubMed ID: 21567193
[TBL] [Abstract][Full Text] [Related]
11. Treatment of diverticular disease of the colon and prevention of acute diverticulitis: a systematic review.
Maconi G; Barbara G; Bosetti C; Cuomo R; Annibale B
Dis Colon Rectum; 2011 Oct; 54(10):1326-38. PubMed ID: 21904150
[TBL] [Abstract][Full Text] [Related]
12. [Modern indications on the medical treatment of symptomatic diverticular disease].
Ierfone N; Di Fulvio A; Pontone S; Terzakis P; Martino G; Pontone P
G Chir; 2006 Mar; 27(3):93-6. PubMed ID: 16681868
[TBL] [Abstract][Full Text] [Related]
13. Review article: uncomplicated diverticular disease of the colon.
Petruzziello L; Iacopini F; Bulajic M; Shah S; Costamagna G
Aliment Pharmacol Ther; 2006 May; 23(10):1379-91. PubMed ID: 16669953
[TBL] [Abstract][Full Text] [Related]
14. Rationale and evidences for treatment of symptomatic uncomplicated diverticular disease.
Cuomo R; Cargiolli M; Andreozzi P; Zito FP; Sarnelli G
Minerva Gastroenterol Dietol; 2017 Jun; 63(2):130-142. PubMed ID: 27973463
[TBL] [Abstract][Full Text] [Related]
15. [Diverticulosis/diverticulitis? What are conservative therapy possibilities?].
Rinas U; Adamek HE
Med Klin (Munich); 2006 Jan; 101(1):49-57; quiz 58-9. PubMed ID: 16418814
[No Abstract] [Full Text] [Related]
16. Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease--a double-blind, randomised, placebo-controlled study.
Tursi A; Brandimarte G; Elisei W; Picchio M; Forti G; Pianese G; Rodino S; D'Amico T; Sacca N; Portincasa P; Capezzuto E; Lattanzio R; Spadaccini A; Fiorella S; Polimeni F; Polimeni N; Stoppino V; Stoppino G; Giorgetti GM; Aiello F; Danese S
Aliment Pharmacol Ther; 2013 Oct; 38(7):741-51. PubMed ID: 23957734
[TBL] [Abstract][Full Text] [Related]
17. Review article: the pathophysiology and medical management of diverticulosis and diverticular disease of the colon.
Tursi A; Papa A; Danese S
Aliment Pharmacol Ther; 2015 Sep; 42(6):664-84. PubMed ID: 26202723
[TBL] [Abstract][Full Text] [Related]
18. Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights.
Strate LL; Modi R; Cohen E; Spiegel BM
Am J Gastroenterol; 2012 Oct; 107(10):1486-93. PubMed ID: 22777341
[TBL] [Abstract][Full Text] [Related]
19. Transient lactose malabsorption in patients affected by symptomatic uncomplicated diverticular disease of the colon.
Tursi A; Brandimarte G; Giorgetti GM; Elisei W
Dig Dis Sci; 2006 Mar; 51(3):461-5. PubMed ID: 16614952
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of different therapeutic strategies in preventing diverticulitis recurrence.
Tursi A; Elisei W; Giorgetti GM; Inchingolo CD; Nenna R; Picchio M; Maiorano M; Penna A; Lecca PG; Brandimarte G
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):342-8. PubMed ID: 23426537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
